What's New? / Nouveautés
Coviden Updates:
- February 16, 2011: English - French
- August 11, 2010: English - French
- July 20, 2010: English- French
- June 4,2010: English - French
Covidien Announces Health Canada Approval for its
Generic Myocardial Perfusion Imaging Kit
-
July 6, 2009 
12kb
Covidien annonce l’approbation de sa trousse
générique d’imagerie de perfusion myocardique par Santé Canada
- le 6 juillet, 2009
13ko
New Important:
Phosphocol® P 32 (Chromic Phosphate P 32 Suspension)
- Letter from Tyco Healthcare (Covidien)
26/03/09 24kb
- Health Canada Endorsed Important Safety Information on
PHOSPHOCOL P32 39kb
- Prescribing Information 37kb
Prospectus
39kb
Partnership Opportunity for CIHR-ICRH's Team Grant:
Clinical Imaging 77kb
Possibilité de partenariat pour la subvention d'équipe de l'ISCR des IRSC en imagerie clinique 80kb
CHALK RIVER REACTOR SHUT DOWN AGAIN
One year after the shutdown of the Chalk River nuclear reactor that jeopardized patient care delivery across the world for more than a month, we are facing another shortage of medical isotopes production. This new acute crisis has the potential to be even worse due to the concomitant shutdown of European reactors for either maintenance or technical problems.
In partnership with Health Canada, the provincial Health Authorities and the producers and distributors of medical isotopes, the Nuclear Community in Canada will do its very best to ensure that the medical needs of the Canadian population are fulfill.
Should you have any question or comments feel free to call the Canadian Association of Nuclear Medicine (CANM) at 613-730-6254.
Jean-Luc Urbain, M.D., Ph.D., FRCPC
President, CANM
Top Canadian Achievements in Health Research:
Call for Applications
CIHR welcomes applications from individuals or teams working in Canada in the health field, including: health researchers; health professionals; administrators and those involved in public health or public policy. Applications will also be accepted from Canadians working abroad. This new competition will recognize Canadian health research achievements that have had a significant impact on health, health care, and health research by improving our understanding of health and human diseases, tackling health challenges, and improving our health system. CIHR has partnered with the Canadian Medical Association Journal (CMAJ) to showcase significant Canadian achievements. The Top Health Research Achievements as selected by an independent review committee will be considered for publication in the CMAJ. Applications must be submitted to CIHR by December 31, 2008.
For more information about the competition or the application process, please refer to the Top Canadian Achievements in Health Research
You may also contact CIHR at 613-952-8965 or by e-mail at geoffrey.hynes@cihr-irsc.gc.ca.
Les plus grandes réalisations du Canada dans la recherche en santé : Appel de demandes
Les IRSC acceptent les demandes de personnes ou d’équipes travaillant au Canada dans le domaine de la santé, dont les chercheurs en santé, les professionnels de la santé, les administrateurs et ceux qui travaillent dans le domaine de la santé publique ou des politiques publiques. Les demandes provenant de Canadiens qui travaillent à l’étranger seront aussi acceptées. Ce nouveau concours permettra de reconnaître les réalisations du Canada dans la recherche en santé ayant eu un impact important sur la santé, les soins de santé et la recherche en santé en nous permettant de mieux comprendre la santé et les maladies humaines, en relevant des défis liés à la santé et en améliorant notre système de santé. Les IRSC ont conclu un partenariat avec le Journal de l'Association médicale canadienne (JAMC) pour présenter les importantes réalisations du Canada. Les plus grandes réalisations seront sélectionnées par un comité d’examen indépendant et pourraient être publiées dans le JAMC. Les demandes doivent être présentées aux IRSC au plus tard le 31 décembre 2008.
Pour de plus amples renseignements sur le concours ou le processus de demande, reportez-vous à la page Web Les plus grandes réalisations du Canada dans la recherche en santé.
Vous pouvez aussi communiquer avec les IRSC au 613-952-8965 ou par courriel à geoffrey.hynes@irsc-cihr.gc.ca.
Letter from Lantheus, October 7, 2008 29kb
Updated information regarding supply of medical
isotopes-Health Canada, September 24, 2008 12kb
Letter from GE Healthcare, September 24, 2008 38kb
Letter from Lantheus, September 22, 2008 36kb
Lessons learned from the shutdown of the Chalk River reactor 186kb posted 07/08/08
Leçons tirées de l'arrêt du réacteur de Chalk River
202kb affiché 07/08/08
Press Releases / Communiqués de presse
posted/affiché 21/05/08
Shortage of Sincalide-Fatty Meals 297kb
posted 21/05/08
Lettre de Covidien/Letter from Covidien 29kb
affiché/posted 25/03/08
Membership Directory/Répertoire des Membres
updated - revisé 10/06/08
Letter to the Honourable George Smitherman 112kb
posted 21/12/05
Report of a Summit on Molecular Imaging
Article reprinted, with permission, from RADIOLOGY,
copyright 2005, RSNA
Proposed Specific Standards of Accreditation for a Program Leading to Registration of Added Competency in Nuclear Cardiology/Cardiac Nuclear Medicine 59kb posted June 2005
Radiopharmaceuticals Submissions Performance Report - BGTD March 31, 2004 155kb posted May 11, 2004
BGTD Performance Report 2003-2004 243kb
posted May 11, 2004
BGTD Directorate 44kb
posted May 11, 2004
Health Canada Regulatory Umbrella for Positron-Emitting Radiopharmaceuticals (PERs) 157kb
posted May 11, 2004
Response to the PER Policy 725KB
posted February 6, 2004
MD Nordion position on FDG licensing in Canada
posted 24/04/03
Regulatory Policy for Positron - Emitting Radiopharmaceuticals - Draft Issue Analysis".
posted 16/08/02
Réponse du Docteur Daniel Picard à Monsieur Greg Monsour, Santé Canada - Politique de réglementation des produits radiopharmaceutiques émetteurs de positrons posted 17/09/02
Response from Dr. Gilbert Matte to Julia Hill. - Regulatory Policy for the Positron - Emitting Radiopharmaceuticals posted 16/08/02
Response from the Federal Government on the CSNM Position Paper on PET Posted 28/06/02
For further information regarding the latest Draft Issue Analysis Summary on the Regulatory Framework for Positron-Emitting Radiopharmaceuticals, please visit Health Canada’s website at:
English: www.hc-sc.gc.ca/hpfb-dgpsa/bgtd-dpbtg/per_dias_tc_e.html
French: www.hc-sc.gc.ca/hpfb-dgpsa/bgtd-dpbtg/per_dias_tc_f.html posted 28/06/02
Following the CSNM presentation to Mr. Romanow on new technology in Montreal last spring, Mr Romanow requested a document describing cost saving/avoidance of the new PET technology on the health care system.
Attached you will find this document,
prepared by both Dr. Picard and Dr. Matte. 148kb
posted 02/07/02